首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Neurology and therapy

缩写:

ISSN:2193-8253

e-ISSN:2193-6536

IF/分区:4.8/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引834
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Paola Zaratin,Per Soelberg Sørensen,Óscar Fernández et al. Paola Zaratin et al.
Using the case study of the Multiple Sclerosis Care Unit Initiative launched by the European Charcot Foundation, we discuss the need to evaluate the impact of multidisciplinary and multi-stakeholder healthcare systems on patient-reported ex...
Chen Zhong,Kang Yang,Nianhua Wang et al. Chen Zhong et al.
Epilepsy, a prevalent neurological disorder characterized by recurrent seizures, affects millions worldwide, with a significant proportion resistant to pharmacological treatments. Surgical interventions have emerged as pivotal in managing d...
Vered Aharonson,Teddy Lazebnik,Alon Sinai et al. Vered Aharonson et al.
Background: Tremor in essential tremor and in tremor-dominant Parkinson's disease is assessed by subjective observations in patients undergoing focused ultrasound thalamotomy, a minimally invasive procedure intended to al...
Caroline Cowan,Richard Walker Caroline Cowan
This is an outline for a podcast. Parkinson's Disease (PD) is a progressive neurodegenerative disease in which there is increasing loss of dopamine neurones from the basal ganglia (Simon et al. Clin Geriatr Med. 36(1):1-12). Motor symptoms,...
Erin Furr Stimming,Daniel O Claassen,Ginny P Sen et al. Erin Furr Stimming et al.
Introduction: Chorea is the primary manifestation of Huntington's disease. Different clinicians pursue varied approaches to chorea management, and real-world evidence describing them is needed. The objective of this study...
Michele Potashman,Katja Rudell,Naomi Suminski et al. Michele Potashman et al.
Introduction: The Friedreich Ataxia Rating Scale-Activities of Daily Living (FARS-ADL) is a validated and highly utilized measure for evaluating patients with Friedreich Ataxia. While construct validity of FARS-ADL has be...
Michele H Potashman,Evan Popoff,Lauren C Powell et al. Michele H Potashman et al.
Introduction: The Friedreich Ataxia Rating Scale-Activities of Daily Living (FARS-ADL) is a valid, highly utilized measure for assessing ADL impacts in patients with Friedreich ataxia. We provide evidence of the psychomet...